The Coronavirus Anxiety Level of Elderly Individuals with Diabetes Mellitus and Associated Factors during the COVID-19 Pandemic

Authors : Sıddıka Ersoy, Seda Pehlivan, Derya Akça Doğan, Mahmut Ateş, Ismail Hakkı Ersoy

Pages : 38-50

Doi:10.46310/tjim.1290771

View : 40 | Download : 43

Publication Date : 2024-01-29

Article Type : Research Paper

Abstract :Background Individuals with chronic diseases are less often presented to hospitals due to the restrictions enforced during the pandemic period and the fear of contracting the disease. The purpose of the present study was to investigate the effects of the anxiety level associated with novel coronavirus on daily life, treatment compliance, and metabolic conditions in elderly diabetes mellitus (DM) patients. Methods This study included 263 patients diagnosed with type 2 DM aged >65 years. The researchers collected the study data through the face-to-face interview method. The Patient Information Form, Coronavirus Anxiety Scale (CAS), Morisky Medication Adherence Scale, Insomnia Severity Index, and the Depression Anxiety Stress Scales (DASS-21) were used for data collection. Results The mean CAS score was 4.25±3.76. Mean CAS scores were higher in the participants who reported a decrease in the frequency of shopping, grocery/market visits, public transport use, hospital visits, and attending routine checks during the pandemic (p<0.05). Furthermore, a significant positive correlation was found between the mean CAS score and the DASS-21 score (p<0.05). There was a significant negative correlation between the mean CAS score and the treatment compliance score (p<0.05). Conclusion The pandemic and coronavirus anxiety have had an adverse effect on daily life, treatment compliance, and metabolic conditions in elderly DM patients.
Keywords : coronavirus, diabetes, elderly, metabolic control, treatment compliance